Latest News

NDM Receives Athena SWAN Silver Award

NDM Receives Athena SWAN Silver Award

Posted 27/04/2015

NDM are pleased to be able to announce that we have successfully achieved the Silver Athena SWAN award. The Athena SWAN Charter recognises and celebrates good practice on recruiting, retaining and promoting women in science, technology, engineering, maths and medicine (STEMM) in higher education.

 

Claudia Turner starts as Strategic Director for the Angkor Hospital for Children

Claudia Turner starts as Strategic Director for the Angkor Hospital for Children

Posted 27/04/2015

Claudia Turner, Senior Research Paediatrician at the Cambodia Oxford Medical Research Unit (COMRU), begins on 21 April as Strategic Director for the Angkor Hospital for Children (AHC), where COMRU is hosted in Siem Reap.  "I am very excited to be taking up such a challenging role at the Angkor Hospital for Children, an amazing institution that ...

Results from VSV-Ebola trial

Results from VSV-Ebola trial

Posted 02/04/2015

Initial results from the Phase 1 trial for the rVSV ZEBOC candidate Ebola vaccine have now been published. The trial found that the candidate vaccine had no serious side effects although some volunteers experienced fever for the first few days after vaccination, and some developed transient pain and/or swelling of their joints. The candidate vaccine was able to raise antibody responses that neutralized Ebola-like virus particles in the laboratory. 

The trial team in Kilifi was led by Dr. Patricia Njuguna with support from Prof Philip Bejon and Dr Benjamin Tsofa.  Although there are no cases of Ebola reported in Kenya, demonstrating safety and immune responses by the vaccine in the Kenyan population will facilitate use of the vaccine if necessary.

World TB Day 2015

World TB Day 2015

Posted 24/03/2015

On March 24th 1882, Dr Robert Koch announced that he had discovered the cause of tuberculosis (TB). 24th March is ‘World Tuberculosis Day’ - an opportunity to raise awareness about the burden of TB worldwide.

Although not that common in the UK (there were 7,892 recorded cases in the UK in 2013), TB is still a big problem in other parts of the world. NDM spoke to Professor Guy Thwaites, Director of theOxford Clinical Research Unit in Vietnam, about the situation in South-east Asia and the ongoing research at OUCRU in to eradicating the disease and improving patient outcomes.

Leading researchers call for tighter control over medicines used in clinical trials

Leading researchers call for tighter control over medicines used in clinical trials

Posted 27/02/2015

There is an increasing body of evidence to suggest that significant quantities of medicines and medical products, especially in low and middle-income countries, are of poor quality. Malaria researcher and drug quality expert Professor Paul Newton, of the Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit in Laos, explains the latest research findings and explores some of the recommendations to improve medicine provision for clinical trials.

Malaria drug resistance confirmed in Myanmar

Malaria drug resistance confirmed in Myanmar

Posted 20/02/2015

Recent reports suggest that artemisinin drug resistance is emerging and spreading in many parts of the Asian Mekong region.

study published today by NDM researchers in Lancet Infectious Diseases reports that the spread of artemisinin drug resistance is following the same historical route as resistance to other antimalarial drugs, chloroquine and sulfadoxine/pyrimethamine.

Ebola: The race to find a cure

Ebola: The race to find a cure

Posted 17/02/2015

In October, scientists from Tropical Medicine set out to do something unprecedented – conduct a drugs trial during an epidemic to find a treatment for a lethal disease. The Guardian has written an interesting account of the trial with insights from Professor Pete Horby, Dr Jake Dunning, Dr Gail Carson, Laura Merson and Professor Trudie Lang. It discusses the difficulties in finding a suitable site, the challenges of dealing with the epidemic, finding the best drug to test in the trial and the problem of having too few patients to enrol. 

Trial of a potential treatment for Ebola begins in Liberia

Trial of a potential treatment for Ebola begins in Liberia

Posted 07/01/2015

A clinical trial of a potential treatment for Ebola has started in Liberia, with the first Ebola patient receiving the study drug on 2 January. The trial aims to evaluate the effectiveness of brincidofovir in patients with Ebola virus disease. Professor Peter Horby the trial's chief Investigator, says: 'I'm delighted that the trial has started. We can only fully evaluate potential Ebola therapies during an epidemic, and we have shown that this is possible, even during the worst epidemic in living memory.' Professor Trudie Lang says: 'There are currently no known treatments for Ebola. Giving drugs on a case by case basis does not enable us to learn whether or not the possible treatments work, therefore it is essential that we run a properly designed trial to be able to test these drugs and see if they are safe and do in fact work.'

NDM excels in REF 2014 exercise

NDM excels in REF 2014 exercise

Posted 18/12/2014

Today’s Research Excellence Framework (REF 2014) results confirm the University of Oxford’s world leading position in medical sciences research. Clinical Medicine ranked top for the overall quality of submissions along with Public Health Service, and Primary Care and Psychology, Psychiatry and Neuroscience. The University of Oxford overall has the largest volume of world leading research and impact submitted to the REF exercise.

François Nosten wins science diplomacy award

François Nosten wins science diplomacy award

Posted 24/11/2014

In mid-Nov, in recognition of his 35 years of work fighting malaria in the conflict zones of the Thai-Myanmar border and for bringing around the same table Karen and Burmese representatives to discuss malaria elimination, François Nosten, director of the Shoklo Malaria Research Unit (SMRU), was awarded the 2014 TWAS Regional Prize for Science ...